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Primary ciliary dyskinesia (PCD) is an inherited chronic respiratory obstructive disease with randomized body
laterality and infertility, resulting from cilia and sperm dysmotility. PCD is characterized by clinical variability
and extensive genetic heterogeneity, associated with different cilia ultrastructural defects and mutations identi-
fied in >20 genes. Next generation sequencing (NGS) technologies therefore present a promising approach for
genetic diagnosis which is not yet in routine use. We developed a targeted panel-based NGS pipeline to identify
mutations by sequencing of selected candidate genes in 70 genetically undefined PCD patients. This detected
loss-of-function RSPH1mutations in four individuals with isolated central pair (CP) agenesis and normal body
laterality, from two unrelated families. Ultrastructural analysis in RSPH1-mutated cilia revealed transposition of
peripheraloutermicrotubules into the ‘empty’CPspace,accompaniedbyadistinctive intermittent lossof thecen-
tral pair microtubules. We find that mutations in RSPH1, RSPH4A and RSPH9, which all encode homologs of
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componentsof the ‘head’ structure of ciliary radial spoke complexes identified inChlamydomonas, cause clinical
phenotypes that appear to be indistinguishable except at the gene level. Byhigh-resolution immunofluorescence
we identified a loss of RSPH4A and RSPH9 along with RSPH1 from RSPH1-mutated cilia, suggesting RSPH1
mutations may result in loss of the entire spoke head structure. CP loss is seen in up to 28% of PCD cases, in
whom laterality determination specified by CP-less embryonic node cilia remains undisturbed. We propose this
defect could arise from instability or agenesis of the ciliary central microtubules due to loss of their normal
radial spoke head tethering.
INTRODUCTION
Cilia are complex, dynamic microtubule-based structures con-
served across eukaryote species that extend as hair-like projec-
tions from the cell surface. Their growth and resorption is
tightly cell cycle-linked, and their components are synthesized
in the cell body then actively transported into the ciliary com-
partment by intraflagellar transport (1–3). Human motile cilia
and flagella (sperm tails) are structurally related and play essen-
tial roles in the motility of fluid and cells. Proteins required for
motile cilia functions may also have roles in cilia assembly
and orientation of cell divisions (4). Motile cilia extend from
the multiciliated epithelial surface of the respiratory airways,
the brain ependyma and fallopian tubes (5). They beat in syn-
chrony with a coordinated ‘whiplash’ motion, forwards and
back within the same plane to achieve fluid flow across their
surface, and the initiation and complex regulation of this
process is under the control of a variety of intracellular and exter-
nal factors (6).
The core axoneme structure of cilia and flagella contains a
central pair (CP) of singlet microtubules (‘CP’) surrounded by
nine doublet microtubules giving a classic ‘9 + 2’ arrangement
when viewed in cross-section. Motile monocilia that initiate
left–right body axis patterning during embryogenesis lack the
CP apparatus in a ‘9 + 0’′ arrangement, and have a circular
beat giving rise to leftward fluid flow across the embryonic
node (7,8). Much of what we know about motile cilia function
is derived from studies of ancient flagellate organisms such as
the single-celled biflagellate green alga Chlamydomonas rein-
hardtii (9). There are a number of microtubule-associated
protein complexes attached along the length of the axoneme in
a regular 96 nm repeat formation that provide axonemal stability
to support the rigors of ciliary beating, whilst tightly governing
the velocity of the beat and the waveform pattern (10). Pairs
(inner and outer) of dynein arm motor complexes attached to
the peripheral doublets are responsible for ATP-generated
ciliary beating which requires coordinated sliding interactions
between the peripheral doublet microtubules of the axoneme.
The complex regulation of ciliary motility is not fully under-
stood, but key structural and regulatory complexes governing
local dynein motor activity are the nexin–dynein regulatory
complexes that link between the peripheral doublets, and the
radial spoke complexes (11). Both of these structures are
located in close proximity to the dynein motors within the
96 nm repeat. The radial spokes are T-shaped assemblies com-
prising at least 23 proteins that are composed of a head and
stalk, which together form a major radial scaffold for mechano-
chemical signal transduction along the axoneme (12). They link
between the CP outwards to the peripherally located dynein
motors, directing ciliary beating waveform and velocity (13).
Primary ciliary dyskinesia (PCD;MIM244400) is a genetical-
ly heterogeneousdisorder arising fromabnormalmotility of cilia
and flagella, associated with defects of the axoneme that are
usually ultrastructurally visible (14). The disease manifests
with an autosomal recessive mode of inheritance and affects
one in every 15 000–30 000 births. The clinical course of
disease can greatly vary and abnormal cilia motility causing de-
ficient mucociliary transport in the airways leads to a number of
symptoms including chronic respiratory infections, rhinosinusi-
tus, effusive otitis media with progression to irreversible lung
damage (bronchiectasis). Dysmotile fallopian tube cilia and
sperm flagella give rise to subfertility that can affect both
sexes in adulthood. Dysfunction of motile embryonic node
cilia arising during development gives rise to situs abnormalities
in approximately half of individuals with PCD. This reflects a
randomized left–right axis determination which usually mani-
fests as clinically harmless situs inversus, however, more
complex laterality defects can give rise to clinically severe iso-
merisms and heart defects in 6% of cases (15).
Genetic studies have highlighted extensive genetic heterogen-
eity underlying PCD within the last decade, and it is sometimes
described as a group of disorders rather than single disease
entity. Although the molecular basis of a significant proportion
of PCD cases still remains unexplained, a number of genetically
stratified patient subgroups can be identified based on ultrastruc-
tural and motility findings in their cilia. Mutations in 27 genes
leading to distinct ultrastructural defects have been reported
(16–22, and references therein).These includemutations instruc-
tural components of the axoneme including the outer dynein arms
(ODA) and their targeting and docking complexes, causing ODA
defects (DNAH5, DNAI1, DNAI2, DNAL1, NME8/TXNDC3,
CCDC114 and ARMC4). Some mutations affecting components
or regulators of the nexin–dynein regulatory complexes cause
microtubule disarrangements and inner dynein arm (IDA) loss
(CCDC39, CCDC40) whilst others do not greatly disturb
axoneme organization (CCDC164, CCDC65), a finding also
noted for mutations affecting an ODA component gene
(DNAH11). Mutations resulting in dual loss of the outer and
IDA have also been identified in genes encoding cytoplasmic or
cytoplasmic/axonemal proteins with roles in the cytoplasmic as-
sembly and/or transport and docking of dynein arm components,
(DNAAF1/LRRC50, DNAAF2/KTU, DNAAF3, CCDC103,
HEATR2, LRRC6, ZMYND10, DYX1C1, SPAG1, C21ORF59).
RPGRmutations appear to cause a syndromic form of PCD (23).
Lastly, mutations in four genes encoding components of the
CP (HYDIN) and the radial spokes (RSPH4A, RSPH9, RSPH1)
all cause a subset of PCD characterized by defects affecting
solely theCP (i.e. CP deficiency/losswithout significant disturb-
ance to other structures). In HYDIN mutant respiratory cilia
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which lack only the C2b projection of the CP (24), the cilia ultra-
structure in fact looksmostly undisturbed and a complete CP loss
is only occasionally seen. CP loss is a muchmore frequently seen
event inRSPH4A,RSPH9andRSPH1mutantcilia, and thismakes
HYDIN a distinct subtype defined by largely normal-looking cilia
requiring electron tomography for their subtle defect to be seen
(20,25). CP loss can occasionally also occur as a component of
other defects, for example, as part of the generalmicrotubular dis-
arrangements caused by CCDC39 and CCDC40 mutations, but
again this is a distinct subtype where CP disturbances form part
of a different overall pattern of defects.
Estimates vary from country to country, but CP deficiency has
been reported to account for as much as 28% of all PCD cases
(26,27). Individuals with CP only-deficient PCDdo not have lat-
erality defects, and the 9 + 0 ultrastructure of the embryonic
nodal cilia would not be predicted to be influenced bymutations
affecting the CP which they lack (28,29). The complete loss of
the CP is typically also referred to as ‘transposition’ defect,
since the affected cilia often display a peripheral doublet trans-
posed into the ‘empty’ CP area to create an aberrant ‘8 + 1’
microtubule pattern viewed in cross-sections, in addition to
having abnormal ‘9 + 0’′ cross-sections (25,29).
The high level of genetic heterogeneity underlying PCD has
previously led to labor-intensive and expensive genetic screen-
ing, especially, since many of the causative genes are large
dyneins. An attractive approach that has not yet been widely
implemented for PCD genetic diagnostics is the use of high-
throughput DNA sequencing techniques offered by next gener-
ation sequencing (NGS), where multiple genes can be analyzed
for mutations in a rapid and cost-efficient way. Here we used an
NGS ‘gene panel’ approach to investigate the genetic basis of
PCD in a cohort of genetically undefined, unrelated individuals,
and demonstrate successful gene identification and sub-
stratification of the CP-deficient form of PCD.
RESULTS
Targeted NGS sequencing identifies RSPH1mutations
in a cohort of PCD patients
We employed an NGS approach to identify the disease-causing
mutations in 70 unrelated individuals with a clinical diagnosis
of PCD. Genomic DNA isolated from peripheral blood samples
was subjected toNGS resequencing of a panel of selected ciliopa-
thy genes. This included all the currently identified PCD-causing
genes, as part of a larger panel containing 150 candidate PCD
genes suggested from our own on-going and collaborative
studies. The next generation sequence data generated was
quality controlled, aligned back to the genome, and annotated
forDNAvariants.The total variant list generated for each individ-
ual was then filtered for consistency with a rare recessive disease
model.This analysis required thepresenceof at least onehomozy-
gous or twoheterozygous changes thatwere either novel or occur-
ring with an estimated frequency ,0.01 in publically available
human exome databases (1000 Genomes, NHLBI EVS,
dbSNP132). Based on pre-existing knowledge of PCDmutations,
we focused especially on non-synonymous or splice-site substitu-
tions and indels, and a final filter was applied to identify variants
present in geneswith putative function inmotile cilia and/or those
present in the Cilia Proteome (30).
The gene panel included the known CP loss/transposition
defect-associated genes RSPH4A, RSPH9 and RSPH1, as well
as HYDIN. Two of five CP loss/transposition defect cases within
the cohort (PCD-166 II:1 and PCD-282 III:1) were found to
carry low-frequency biallelic variants in the 1.4 kb, 8 exon
RSPH1 cDNA sequence, which spans 24 kb on chromosome
21q22.3. The variants identified in the rest of the cohort are cur-
rentlyunderanalysis.The sequencingandfiltering results for indi-
viduals PCD-166 II:1 and PCD-282 III:1 are shown in Table 1.
Both are females with typical symptoms of PCD including neo-
natal respiratory distress episodes. In later life both continued to
suffer chronic disease symptoms of productive cough, rhinitis
and sinusitis, recurrent respiratory infections and congestive
lung symptoms. Other documented signs in both cases were ear
infections and otitismedia, which had led to hearing problems re-
quiring grommet surgery, and both also had bronchiectasis. Nasal
nitric oxide in PCD-166 II:1 was greatly reduced consistent with
other PCDpatients,measuring 50 and 79 ppb in independent tests
[normal range .200 ppb; (31) no data available for family
PCD-282]. Twosiblings inPCD-282were also similarly affected.
Of 17 genes in PCD-166 II:1 showing biallelic variants
meeting the filtering criteria, searches for putative motile cilia
function applied as a final filter showed variants of interest
were present in only two genes that were implicated in motile
cilia function: DNAH12 and RSPH1 (Table 1). Of 16 genes in
PCD-282 III:1 with biallelic variants, this final filter detected
biallelic variants in five genes with possible motile cilia roles:
DNAH1, DNAH3, WDR66, CCDC40 and RSPH1 (Table 1).
Since the ciliary ultrastructural defects in the two cases were
not compatible with mutations in dynein arm components, this
excluded the DNAH12, DNAH1 and DNAH3 mutations as a
likely cause. CCDC40 causes PCD with a different defect of
microtubule disorganization and IDA loss (32), not seen in
these cases, and WDR66 although highly expressed in ciliated
tissues has an unknown function (33). Furthermore, for the
CCDC40 and WDR66 variants we performed segregation ana-
lysiswhichexcluded themutations inbothas likely tobedisease-
causing, since unaffected individuals fromPCD-282also carried
both the variants in homozygous form (data not shown).
Of all these putative disease-causing variants, only RSPH1
carried nonsense mutations in the two affected individuals
(Table 1). PCD-166 II:1 from a non-consanguineous Caucasian
pedigree carried compound heterozygous RSPH1 variants con-
sisting of a splice-site change c.275-2A.C affecting one of
the100%conserved exon4 splice acceptor bases, and anonsense
variant in exon 4, c.281G.A; p.Trp94∗. PCD-282 III:1 from a
consanguineouspedigree carried anearlyhomozygousnonsense
variant in exon2, c.85G.T; p.Glu29∗.All three variants are pre-
dicted to cause amajor deleterious change to theRSPH1protein,
consistent with previous reporting that PCD is a ‘null’ allele
disease, and they were all confirmed by Sanger sequencing
(Fig. 1B). The c.275-2A.C splice change and c.85G.T non-
sense allele have recently also been reported by Kott et al. (20)
to cause PCD, whilst the identification of the c.281G.A non-
sense change provides further support for RSPH1 as a new
gene which causes PCD when mutated. The unreported
c.281G.A mutation is the only one of the three variants found
to be completely unique, since c.85G.T is carried by 5/6,500
and c.275-2A.C by 9/6500 unaffected individuals in heterozy-
gous state in theNHLBIEVS control exomedatabase.However,
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given the expected disease and carrier frequencies for PCD,
these rare, non-biallelic, occurrences in unaffected carriers are
still consistent for being deleterious PCD-associated alleles.
Segregation analysis was performed in available members of
the two pedigrees, and this confirmed their recessive inheritance
consistentwith disease status in both families (Fig. 1A andB). In
total four affected individuals in both familieswere confirmed to
carry RSPH1 mutations, none of whom had laterality defects,
which is consistent for CP loss/transposition defects (Fig. 1A).
PCD-166 II:1 is too young to have information about fertility
status, but notably the affected female III:1 from family
PCD-282 has infertility problems. Furthermore her affected
sibling, III:4 of pedigree PCD-282, was infertile and not able
to conceive over 3 years despite a check-up before in vitro fertil-
ization (IVF) which found no anomalies; III:4 gave birth tomale
twins, but only after IVF.
Wemodeled the identifiedmutations in the context of the pre-
dicted RSPH1 protein structure, to understand more about their
possible mutational effect. A consensus structure defined from
Uniprot, Pfam and SMART analysis identified the key
domains ofRSPH1 to be seven predictedMORN(membrane oc-
cupation and recognition nexus) repeats (Fig. 2A). The
c.281G.A variant newly reported in this study is located very
close to the c.275-2A.C splice change also affecting exon 4,
and both mutations as well as c.85G.T are located in one of
the seven MORN repeat regions (Fig. 2A). MORN repeats
have a consensus 23 amino acid sequence and impose a predict-
able tertiary structure on the protein (Fig. 2B). They have been
proposed to influence various essential protein functions such
as membrane binding, enzymatic activity, to facilitate protein
scaffold formation, and regulate a protein’s accessibility to
lipids (34). RSPH1 is also known as meichroacidin or TSGA2
(testis specific A2 homolog), a highly conserved axonemal
protein essential for sperm flagellum formation and the produc-
tion of functional sperm in mutant mice (35,36).
RSPH1 is considered to be the homolog of C. reinhardtii (Cr)
CrRSP1, one of the five subunits of the radial spoke head proteins
that exist in this species as a multiprotein complex, whereby
CrRSP1 together with CrRSP4, CrRSP6, CrRSP9 and CrRS
P10 forms the radial spoke head (12,37). Human RSPH1 also
has homology to CrRSP10, another MORN radial spoke head
protein, however CrRSP10 is more diverged from RSPH1 than
CrRSP1 at sequences surrounding the MORN repeats, thus
CrRSP1 is more likely to be the true homolog (Fig. 2D). We
also compared the predicted structures of the human RSPH4A
and RSPH9 proteins to human RSPH1 since they all associate in
the same ciliary complex and can all carry PCD-associatedmuta-
tions. However, no extensive similarities outside of the MORN
repeats were apparent (Fig. 2C).
RSPH1mutations cause a specific pattern of intermittent
and complete ciliary CP loss, accompanied by transposition
defects
Transmission electron microscopy (TEM) of respiratory cilia
cross-sections from affected individuals PCD-166 II:1 and
Table 1. Summary of gene panel sequencing data filtering process
PCD-166 II:1 PCD-282 III:1
Total variants 5064 5612
Variants with MAF, 0.01 587 669
Heterozygous, MAF, 0.01 462 514
Heterozygous non-synonymous, splice-site, or
insertion/deletion variants
130 92
Genes with compound heterozygous variants 8 9
Genes with motile cilia functions 2
DNAH12a:
c.5093G.A; p.Pro1698Leu
&
c.3577C.A; p.Ala1193Ser (rs2016874)
RSPH1:
c.281G.A; p.Trp94∗
&
c.275-2A.C splice site (rs1511075)
2
DNAH1a:
c.3103C.T; p.Arg1035Cys
&
c.12090 + 7A.C splice site (rs180991820)
DNAH3a:
c.5368T.A; p.Ile1790Phe (rs148202152)
&
c.7C.T; p.Ala3Thr
Homozygous, MAF, 0.01 125 155
Homozygous non-synonymous, splice-site or
insertion/deletion variants
9 7
Genes with motile cilia functions None 3
RSPH1:
c.85G.T; p.Glu29∗
WDR66b:
c.186-187ins of 15 base-pairs; p.62-63insEEEEK (rs142042908)
CCDC40c:
c.3040-3041insCAC; p.1014insThr (rs10693712)
aDynein heavy chain mutations not expected to cause PCD with central pair (CP) loss.
bWDR66 is upregulated during ciliogenesis, but not previously associated with PCD.
cCCDC40mutations cause PCD with disorganized microtubules and inner dynein arm (IDA) loss, not CP-only loss.WDR66 and CCDC40 were excluded by
segregation analysis. MAF, minor allele frequency.
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PCD-282 III:1 revealed loss of the CP apparatus with a 9 + 0
pattern in 11%and 22%of cilia in PCD-166 II:1 in two separate
samples, and cross-sections with 8 + 1 transposition events
more rarely seen (Fig. 3B). PCD-282 III:1 showed similar
results with 30% of cross sections having the 9 + 0 pattern of
absent CP, while 4% had 8 + 1 transposition events
(Fig. 3B). The ciliary beat frequency and beat pattern of
RSPH1-mutated cilia was measured and for both PCD-166
II:1 and PCD-282 III:1 the mean CBF at 378C was in the
normal 7.5–15.5 Hz range (28), measuring 11.7 and 11.4 Hz,
respectively. This normal level of beating is consistent with
the intact retention of the inner and ODA that is seen in TEM
of the cilia fromboth cases. However, despite normal range fre-
quency, a mixed beat waveform consisting of mostly stiff,
unbending and uncoordinated cilia of reduced amplitude was
evident for both patients, when viewed from the side (Supple-
mentary Material, Videos S1, S3, S5). Viewed from above,
regions with a circular beating pattern instead of the normal
forward and backward planar motion were in both patients
(Supplementary Material, Videos S2, S4). This apparently cir-
cular appearance of the beating pattern is characteristic of
ciliary CP loss/ transposition defects previously reported, and
it has been considered to be reminiscent of CP less 9 + 0
nodal monocilia (25,28).
From these results we concluded that the frequency of 9 + 2,
9+ 0 and 8 + 1 ultrastuctural defects in individuals carrying
RSPH1 mutations is similar to that of individuals we previously
reported with mutations in RSPH9 (25), with the CP absent
in 20% of cross-sections (9+ 0) and transposition events (8+
1) captured in , 5%. We examined longitudinal sections of
RSPH1-mutated cilia in TEM to understand the reasons for this
more clearly. We were able to image transposition events in both
individualsPCD-166 II:1 andPCD-282 III:1,wherebyoneperiph-
eral doublet was transposed to the apparently empty space left in
absence of a CP (Fig. 3A, white arrows). These transposition
events tended to be towards the distal end of the cilia,
corresponding to 8 + 1 cross sections. Immediately below, i.e.
towards the cell body, the axonemes completely lacked the CP,
corresponding to 9 + 0 cross sections. Even further towards the
cell body and the basal body, an apparently remnant CPwas inter-
mittently visible in some images that captured cilia in longitudinal
section (Fig. 3A, arrow heads). This intermittent CP pattern is
similar to that of individuals we previously reported with muta-
tions in RSPH9 (25).
Figure 1.Sanger sequencing showing familial segregation of theRSPH1mutations. (A) Pedigrees of familieswithRSPH1mutations found in this study, demonstrat-
ing segregation consistent with autosomal recessive inheritance. (B) Sanger sequencing confirmed the segregation of three RSPH1 mutations as indicated in the
pedigrees.
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RSPH1mutations cause specific loss of the radial spoke
‘head’ domains from cilia, leaving the radial spoke ‘stalk’
domains intact
In order to further understand the genetic basis of the CP loss/
transposition defect in PCD, in particular the connection to
radial spoke head deficiency, we first analyzed the subcellular lo-
calization of RSPH1 using high-resolution immunofluorescence
microscopy inciliated epithelial cells. For this and subsequent im-
munofluorescence analysis, comparative images were taken with
the same settings on the microscope to attempt to directly assess
differences in fluorescence intensity. Whilst RSPH1 protein
Figure 2. Structural models of RSPH1, RSPH4A and RSPH9 showing location of the RSPH1 mutations. (A) The predicted structure of RSPH1 is shown with the
position of the three identified mutations shown in relation to the gene and protein structure. RSPH1 has a low complexity region (yellow) at amino acid residues
238–251, and seven predicted MORN repeats (gray) according to Pfam and detailed in (B), consistent with the predicted structure of the mouse homolog (35).
The Pfam consensus structure was chosen because Uniprot and SMART each predict six of these MORNs, but two are non-overlapping. (B) The three dimensional
RSPH1 protein structure as predicted by I-TASSER is shown, with the seven MORN repeats highlighted at amino acid residues 26–43 (red), 44–66 (cyan), 67–89
(green), 90–112 (magenta), 113–133 (orange), 137–152 (purple) and 159–181 (yellow), in relation to the p.Trp94∗ and p.Glu29∗ nonsensemutations. (C) Shown in
comparison to (A) are the protein structures of RSPH4A containing low complexity regions at residues 29–45, 53–66 and 80–100 (yellow) and a conserved region
termed the ‘radial spoke domain’ at 207–697 (pink); andRSPH9containing lowcomplexity regions at residues 5–21 and 250–268. (D) Protein alignments of human
(Hs) andC. reinhardtii (Cr) MORN repeat proteins of the radial spoke head show that the size of human RSPH1 (309 amino acids) is closer to CrRSP10 (216 amino
acids) than CrRSP1 (814 amino acids). However, multiple sequence alignments and phylogenetic analyses support the genome annotation that RSPH1 closer resem-
bles CrRSP1, which is 500 amino acids longer but has more similar sequences to RSPH1 outside of theMORN repeats (shown in pink). Human RSPH1 and CrRSP1
spoke head proteins therefore appear to have diverged in the sequences flanking their MORN motifs.
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decorated the entire axonemal length in cilia from a control indi-
vidual (Fig. 4A), reduced levelswere observed along the length of
cilia in both PCD-166 II:1 and PCD-282 III:1 when compared
with control individuals (Fig. 4B andC). This provides confirma-
tory evidence that the mutations identified in the two families are
disease-causing changes deleterious to protein function as
predicted.
We then used antibodies targeting proteins localized in either
the head domain (RSPH4A and RSPH9, both implicated in
PCD), or the stalk domain (ROPN1L) of the radial spokes.
RSPH4A and RSPH9 are homologs of the Chlamydomonas
spoke head proteins RSP4 and RSP9 (12). ROPN1L, a ropporin
family protein, is the homolog of Chlamydomonas RSP11 colo-
calizing with RSP3 towards the base of the radial spoke within
the radial spoke ‘stalk’, and ROPN1L-deficient mice display
sperm dysmotility (38,39). This immunofluorescence analysis
revealed a marked reduction in levels of both RSPH4A and
RSPH9 spoke headmarkers from the ciliary axonemes of indivi-
duals carrying RSPH1 mutations compared with controls
(Fig. 5A and B). In addition, an increased staining of RSPH4A
was noted in the periciliary region and cytoplasm, suggesting
the possibility that an accumulation of this protein in these com-
partments occurs as a result ofRSPH1deficiency. In contrast, the
spoke stalk marker ROPN1L remained largely unaffected in
RSPH1-mutated cilia, with staining similar to that of control
cilia (Fig. 6A). This evidence supports the proposed role for
RSPH1 in the human radial head spoke formation, and suggests
that deficiency of RSPH1 affects only the spoke head structure
but leaves the spoke stalks intact. This is similar to findings in
Chlamydomonas mutant strains lacking radial spoke head pro-
teins, in which the radial spoke stalk complex is not disturbed
(12,37). In this study, the mislocalized RSPH4A staining
(Fig. 5A) suggests it is possible that when RSPH1 is depleted,
other non-assembled radial spoke head components being still
produced in the cell might accumulate outside of the cilia
axoneme compartment. A slight cytoplasmic accumulation of
ROPN1L can also be observed in RSPH1-deficient cells indicat-
ing there could also be some level of impeded assembly of spoke
stalk components as well (Fig. 6A), however this is much less
marked.
Finally, we also used twowell-established diagnosticmarkers
of axoneme integrity DNAH5 and DNALI1 to confirm that
defects in RSPH1 do not affect the dynein arm based motors,
as was suggested by the TEM analysis showing their apparent
retention in RSPH1-mutated cilia. DNAH5 and DNALI1
antibodies specifically stain the outer and IDA, respectively,
and we confirmed that the ODAs and IDAs were not perturbed
as a consequence of RSPH1 mutations since the staining
pattern was similar in affected individuals compared with con-
trols (Fig. 6B and C).
DISCUSSION
Here we have shown that mutations in RSPH1 are associated
with PCD characterized by deficiency and loss solely of the
central microtubular apparatus from cilia. RSPH1 is the
homolog of Chlamydomonas RSP1, encoding a radial spoke
‘head’ protein, and it is the third radial spoke head gene in
which PCD-causing mutations have been identified, in addition
to RSPH4A and RSPH9. Individuals with RSPH1, RSPH4A and
RSPH9 mutations represent a subtype of disease that has not
been associated with disturbances of left–right body patterning
(20,25,29). We report immunofluorescence analysis showing
that RSPH1-mutated cilia lack RSPH1 protein, as well as the
other radial spoke head components RSPH4A and RSPH9, but
not the spoke stalk protein ROPN1L. The major ciliary MORN
motif protein RSPH1 is therefore critical for the assembly of
the radial spoke head, and RSPH1-mutated cilia are likely to
lack the entire spoke ‘head’, but to retain the spoke ‘stalk’ struc-
tures (40). It is not easily possible to visualize the spoke heads in
Figure3.Ciliaryultrastructural defects in individuals carryingRSPH1mutations
reveal distal central pair (CP)-deficient transpositiondefects sometimes retaining
intermittent CP proximally. (A) Representative longitudinal TEM of affected
individuals PCD-282 III:1 (left) andPCD-166 II:1 (right) shows the transposition
event characteristic of the CP-deficient cilia. This occurs when a peripheral
microtubule doublet is found in the central area of the cilium, in place of the
central microtubule pair (white arrows) and this corresponds to an 8 + 1
pattern in cross-sections. Towards the cell body immediately beneath the trans-
position event the central area is visibly ‘empty’, lacking the CP completely,
which corresponds to a 9 + 0 pattern in cross-sections. Further below, a partial
CP is visible as a stump extending up from the base of the cilium, and this can
sometimes be captured as having an intermittent appearance, apparently
coming in and out of the plane of section (white arrow heads in PCD-282 III:1,
left), however this ‘intermittent’ CP is not always visible in sections, as seen in
individual PCD-166 II:1. Scale bar, 500 nm (B) Examples of transmission elec-
tron micrographs of cilia from the same affected individuals shown in cross
section compared with control (9 + 2), showing they can have either a normal
9 + 2 arrangement, or 9 + 0, whilst more occasionally 8 + 1 sections are also
seen. Scale bar, 100 nm.
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clinical TEM images from PCD patients, however Chlamydo-
monas mutant strains deficient for the homologous radial
spoke proteins display reduction/loss of the entire head
domain of the radial spokes whilst the radial spoke stalks are
preserved (40,41).
We have investigated the underlyingmolecular basis of radial
spoke head-deficient PCD disease in order to determine the
reasons for CP loss. TEM analysis in longitudinal section iden-
tified transposition defects in RSPH1-mutated cilia, with
absent CP and a peripheral microtubule doublet transposed
into the space where the CP would normally be, towards the
distal half of the cilia. We also discovered that an intermittent-
appearing remnant CP can sometimes be seen, located proxim-
ally to the transposition event, towards the base of the cilia. Al-
ternatively, because this was rarely possible to capture, this
space is mostly seen as ‘empty’ with an apparent short
remnant CP ‘stub’ sometimes visible at the cilia base. It seems
likely that this loss, inability to extend, or partial retention of
the CPr could result from a lack of its normal radial tethering
within the axoneme (as provided by the radial spoke heads).
Loss of the spoke heads, and a relative loosening of the central
microtubules from their normal spokehead-directed radially-
tethered confines could potentially allow them greater move-
ment within the axoneme with a consequent loss of stability
(or inability to form at all), such that the CP rotates in and out
of the plane of the TEM section giving the intermittent appear-
ance we captured.
We have observed this type of intermittent CP pattern before in
RSPH9- (and RSPH4A-, unpublished data) mutated cilia, when
these other radial spoke head proteins are deficient (25). We and
others have previously reported that PCD-causing mutations in
RSPH4A andRSPH9 cause similar ciliary ultrastructural andmo-
tilitydefects (25,42,43).This provides evidenceof a commonmo-
lecular basis for the CP loss/transposition defects that result from
mutations in any of the RSPH1, RSPH4A or RSPH9 genes. In
radial spoke head-deficient cilia, by inference from studies in
Chlamydomonas, a disconnect between the radial spokes and
CPwould explain the replacement of the normal planarwaveform
(propelling the cilia forwards and backwards within the same
plane) by the apparent circular movement that was recorded
here in RSPH1-deficient cilia and elsewhere in RSPH4A- and
RSPH9-mutated cilia (13,25,42). Studies of non-planar (circular)
embryonic node cilia indicate that planarmotion is directedby the
presence of a CP (7). Our results show that RSPH1 and radial
spokehead function is essential for the control of the ciliarywave-
form, to create thenecessarybeatingpattern and force required for
effectivemucociliaryclearanceandotheraxonemalmotilityfunc-
tions in the body.
Figure 4. Individuals carrying RSPH1mutations lack RSPH1 protein along the length of the axoneme. High-resolution immunofluorescence analysis in respiratory
epithelial cells obtained by nasal biopsy is shown in unaffected controls comparedwith individuals carryingmutations inRSPH1with anti-acetylated-a-tubulin used
as a marker to stain the entire axoneme (red) compared with anti-RSPH1 (green), with nuclei DAPI-stained to show the DNA (blue). (A) RSPH1 protein is detected
along the length of the cilia in a healthy individual. Individuals PCD-166 II:1 (B) and PCD-282 III:1 (C) have markedly reduced levels of RSPH1 protein. Scale bars
represent 10 mm.
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Notably in Chlamydomonas, mutations in radial spoke head
proteins results in dysmotility with loss of the head (but not
stalk) domain of the radial spokes, however there is no accom-
panying loss of the CP (40,41). This different from the effect
of the equivalent mutations underlying human PCD shown
here.Chlamydomonas flagella have a characteristic asymmetric
‘breast stroke’ waveform that is quite distinct from the single-
plane ‘whiplash’ pattern of human cilia motility, and the CP
has significantly more movement within its axoneme compared
with humans (44,45). The cross-species difference in CP reten-
tionuponmutationof the spokeheads is likely to reflect thesedif-
ferences in local control of axonemal waveform kinetics, with
different resultant stresses on the CP affecting their formation
and/or preservation differently.
This study has demonstrated that sequencing of a candidate
NGSgenepanel can identifyPCD-causingmutations, andcandis-
tinguish between CP-deficient disease subtypes arising from
RSPH1, RSPH4A and RSPH9 mutations. CP loss/transposition
defects account for up to 28% of PCD and these can be difficult
to diagnose clinically, since affected individuals have normal lat-
erality and cilia beat frequency around the normal range. Careful
viewingofhigh-speedvideo isalso required to fully appreciate the
reduced amplitude and circling beat of their cilia. Our results can
help in diagnosis of these difficult cases, showing that 20% of
their cilia will be visible as either 9 + 0 or 8 + 1 arrangement.
The presence of intermittent CP is, in our experience, unique to
RSPH1-, RSPH4A- and RSPH9-mutated cilia deficient for
radial spoke head mutations. This is distinguished from
Figure 5. Individuals carryingRSPH1mutations lack other proteins of the radial spoke head suggesting the entire structuremay be absent. High-resolution immuno-
fluorescence analysis in respiratory epithelial cells obtained by nasal biopsy is shown in unaffected controls comparedwith individuals carryingmutations inRSPH1
with anti-acetylated-a-tubulin used as amarker to stain the entire axoneme (red) comparedwith twomarkers of the radial spoke head complex that are also implicated
in PCD, anti-RSPH4Aand anti-RSPH9 (both green). Nuclei areDAPI-stained to show theDNA (blue). (A) RSPH4Aand (B) RSPH9proteins decorate the entire cilia
in healthy individuals whilst levels of both proteins in PCD-166 II:1 are severely reduced. Scale bars represent 10 mm.
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Figure 6. Individuals carrying RSPH1mutations retain markers of the radial spoke stalk and the inner and outer dynein arms (ODA). High-resolution immunofluor-
escence analysis in respiratory epithelial cells obtained by nasal biopsy is shown in unaffected controls comparedwith individuals carryingmutations inRSPH1with
anti-acetylated-a-tubulin used as a marker to stain the entire axoneme (red) compared with a marker of the radial spoke stalk complex, anti-ROPN1L (green) and
antisera against the ODA protein DNAH5 and the inner dynein arm (IDA) protein DNALI1 (green). Nuclei are DAPI-stained to show the DNA (blue). (A)
ROPN1L, (B) DNAH5 and (C) DNALI1 immunostaining in PCD-166 II:1 is unaltered compared with healthy individuals. Scale bars represent 10 mm.
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HYDIN-associatedCPdefectswhichdisplayonlyveryoccasional
absence of the CP. Since the clinical and molecular phenotypes
conferred by mutations in any of the three radial spoke head
genesRSPH1,RSPH4A andRSPH9 appear tobebroadly indistin-
guishable, genetic testing presents the onlymethod to distinguish
between these different defects.
The future application of this type ofNGS technologywill be in
continuing to provide increasingly more comprehensive diagnos-
tic testing for PCD, similarly to the progress shown here in devel-
opment of diagnostic gene panels, compared with current
methodologies available through UK diagnostic laboratories. It
will facilitate in defining the PCDmutational spectrum across dif-
ferent populations, thereby increasing our current knowledge of
the genetic architecture underlying PCD and the overall medical,
health economic and societal impact of the disease in the UK
and beyond. Broadening the availability of genetic testing will
benefit affected families with PCD, primarily in promoting more
effective and earlier diagnosis which has clearly been linked to
improved disease outcomes (46), and also in assisting more rapid
and informed genetic counseling for affected families.
MATERIALS AND METHODS
Subjects and ethics statement
Criteria for inclusion to the studywere a diagnosis of PCD based
upon documentation of typical symptoms including neonatal re-
spiratory distress and chronic respiratory symptoms including
rhinosinusitis, bacterial infections and fluid congestion, otitis
media, bronchiectasis. Clinical tests were also documented in
the cohort comprising light and electron microscopy findings
showing ciliary motility and structural defects, and reduced
nasal nitric oxide levels. Genetic studies were approved by the
ethical committees of the Institute of Child Health/Great
Ormond Street Hospital (#08/H0713/82) and the Comite´ de
Protection des Personnes Ouest IV and Sud-Est II. Studies of
unaffected individuals were separately approved by the Univer-
sity College London Research Ethics Committee (3187/001).
Informed consent was obtained from all participants prior to
history recording, blood drawing and nasal biopsy.
NGS replication gene panel sequencing, alignment,
variant detection and annotation
Whole genome amplified DNA (2 mg) was fragmented to an
average size of 150 bp and subjected to library creation using
established Illumina paired-end protocols (Illumina Inc.,
USA). Adapter-ligated libraries were amplified and indexed
via PCR.A portion of each librarywas used to create an equimo-
lar pool comprising 16 indexed libraries. Each pool was hybri-
dized to SureSelect RNA baits and sequence targets were
captured and amplified in accordance with the manufacturer’s
recommendations. Enriched libraries were subjected to 75
base paired-end sequencing (HiSeq 2000; Illumina). For the
bait design process the SureSelect Target Enrichment protocol
was used (Agilent SureDesign wizard, Agilent Technologies,
USA), and probes were selected to target the coding exons of
genes based on their Ensembl canonical ID, or by manually de-
fining probe target regions where this failed. The NGS gene
panel was processed at the Wellcome Trust Sanger Institute
(Cambridge, UK) as part of the UK10K Project. The 150 PCD
candidate genes included to the screen formed part of a larger
collaborative project covering many disease candidate genes,
such that in total there were 1223 gene targets comprising
19897 chromosomal regions, with a total region size of
3.348 Mb. This resolved to 50107 probes covering 4.512 Mb
with 100% target coverage. The probe tiling parameters used a
tiling density of 1×, no masking and balanced boosting.
TheBWAalignment tool (47)wasused tomap sequence reads
back to the genome (human reference hg19). To process the
alignments and identify variations (SNPs and indels) we used
both SAMtools mpileup (0.1.17) (48) and GATK UnifedGen-
otyper (1.3–21) (49), restricted to bait regions plus or minus a
100 bp window. Various quality filters were applied to each of
thecallsets separatelyandcallswere thenmerged,givingpreference
to GATK information when possible. The SNP-Effects (http://
snpeff.sourceforge.net/) and ANNOVAR (50) programs were
used to annotate variations. Variant calls were annotated with
1000 Genomes allele frequencies (http://www.1000genomes.
org/) and dbSNP132 rs ID numbers (51). Ensembl Variant
Effect Predictor v2.2 analysis applied against Ensembl 64 was
used to add functional annotation including coding consequence
predictions, SIFT, PolyPhen and Condel annotations, and GERP
and GranthamMatrix scores. Filters were applied to the resulting
candidate gene variant profiles using the EVAR software tool
v.0.2.2 beta. Variants present in 1000 Genomes, NHLBI-ESP
exome variant server (http://eversusgs.washington.edu/EVS/)
and dbSNP132 with a minor allele frequency .0.01 were
removed, then variants not consistent with autosomal recessive
in-heritance (biallelic changes). Variants were finally screened
for possible motile cilia function, and for their presence in the
Cilia Proteome (30).
Sanger sequencing
The RSPH1 transcript ID is RefSeq NM_080860.2. Variants of
interest were amplified by PCR using primers designed with the
Primer 3 web application (http://frodo.wi.mit.edu/primer3).
Sequences and PCR conditions are available upon request.
Sequences were analyzed compared with controls using Sequen-
cher software (Gene Codes Corporation, Ann Arbor, MI, USA).
Electron microscopy and high-speed video light microscopy
Respiratory epithelial cells were obtained using a cytology brush
or rhinoprobe fromthe inferior turbinateofparticipantsandimme-
diately analyzed for cilia beat frequency (CBF) and beat pattern at
378C under light microscopy as described (28). Samples were
fixed in glutaraldehyde as previously described and an ultrastruc-
tural defect of the cilia was confirmed by TEM on a minimum of
100 cross sections and longitudinal sectionswhere available (52).
ElectronmicrographsandCBF fromcaseswithRSPH1mutations
were reviewed by one person (A.S.).
In silicomodeling of protein structure
The protein sequences used were taken from Swissprot for
RSPH1 (Q8WYR4), RSPH4A (Q5TD94) and RSPH9 (Q9H
1X1). Sequence and comparative phylogeny analysis was per-
formed using Clustal Omega (http://www.clustal.org/omega/).
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Structural models of human RSPH1, RSPH4A and RSPH9were
generated by comparing the output from SMART (53), Uniprot
(http://www.uniprot.org/) and Pfam (http://pfam.sanger.ac.uk/)
programs. The predicted number of MORN repeats varies
between programs because the definition of these domains is
weak, based on a fewamino acid residues at conserved positions.
Predictions can also use data about the secondary structure, the
position and predicted repeat number, thus the repeat numbers
of such motifs predicted by various programs can differ, some
definitions being stricter than the others. As explained in
Figure 1 legend, the Pfam consensus showing seven MORN
repeats in RSPH1 may be preferred over Uniprot and SMART
which each predict six of these MORNs with two non-
overlapping. The three dimensional model was created using
I-TASSER (54).
Immunofluorescence microscopy
Respiratory epithelial cells obtained by nasal brush biopsy from
affected participants and controls were suspended in cell culture
medium. Samples were spread onto glass slides, air dried and
stored at2808Cuntil use. Cells were fixedwith 4% paraformal-
dehyde for 4 min at room temperature, washed five times with
phosphate buffered saline (PBS) and then permeabilized with
0.5% Triton X-100 for 10 min. After five more PBS washes,
cells were incubated with 5% bovine serum albumin
(Sigma-Aldrich, Dorset, UK) in PBS for 1 h. The cells were
then incubated with primary antibodies overnight at room tem-
perature using the following dilutions: axoneme-specific
acetylated-a-tubulin monoclonal mouse antibody (Sigma
T6793 6-11B-1, diluted 1:1000) to stain the entire axoneme,
and rabbit polyclonal antibodies against RSPH1 (HP017382,
Sigma, 1:100), RSPH9 (HPA031703, Sigma, 1:200), RSPH4A
(HPA031196, Sigma, 1:75) and ROPN1L (HPA039193,
Sigma, 1:100), to detect radial spoke proteins. Antibodies to
DNAH5 (HPA037470, Sigma, 1:200) and DNALI1
(HPA028305, Sigma, 1:200) were used to confirm outer and
IDA integrity, respectively. After five washes with PBS, cells
were incubated with secondary anti-rabbit antibody (Alexa
Fluor 488 Molecular Probes; Life Technologies, Paisley, UK)
and secondary anti-mouse antibody (Alexa Fluor 594Molecular
Probes; Invitrogen) used at 1:1000 dilution. DNA was stained
using DAPI (Life Technologies, Paisley, UK). Cells were
finally washed five times with PBS, mounted in Vectashield
(Vector Laboratories Ltd., Peterborough, UK) and confocal
images were taken using a Zeiss LSM 710 (Zeiss Ltd.,
Cambridge, UK).
SUPPLEMENTARYMATERIAL
Supplementary Material is available at HMG online.
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